Letter to Editor
An update on CT chest findings in coronavirus disease-19 A recent outbreak of Coronavirus 2019 (SARS-CoV-2) has shattered the world and has been declared a pandemic by World Health Organization (WHO) on 11th March 2020 ( Fig. 1 ). 1, 2 When clinicians worldwide are actively suspecting cases and treating those, who test positive for Coronavirus disease 2019 (COVID-19), at the same time the radiologists are also contributing by interpreting chest computed tomography (CT) scans of COVID-19 patients. We hereby discuss the recently conducted studies analyzing the CT findings of COVID-19 cases. 3À5 Bernheim et al. outlined the radiological findings in 121 patients in relation to the time between symptom onset and conducting the 1st CT scan on these patients. 3 They stratified their patient cohort into 3 groups- [1] Early subgroup, defined as patients who presented between 0 and 2 days (36 patients), [2] Intermediate subgrosup, defined as those who presented between 3 and 5 days (33 patients), [3] Late subgroup, defined as those who presented between 6 and 12 days (25 patients). They reported that 56% of the early subgroup patients (20/36) had normal CT findings. On doing the follow-up CT scans of all the 3 subgroup patients, Bernheim et al. found that, the more the time duration between symptom onset and getting a follow-up CT scan, the more the CT findings were detected. Follow-up CT scans also confirmed an increasing percentage of bilateral lung involvement from 28% in early patients to 88% in late patients.
With regards to the common CT imaging findings, most studies reported ground-glass opacities (GGOs), consolidation, and interlobular thickening as the common abnormalities ( Table 1 ). The frequency of lobe involvement was also studied and Bernheim et al. found the right (65%) followed by the left (63%) lower lobe as the most common site of involvement. Similarly, Wu et al. reported the dorsal segment of the right lower lobe (69/80 cases, 86%), a posterior basal segment of the right lower lobe (68/80 cases, 85%), and the lateral segment of the right lower lobe (64/80 cases, 80%) as the top 3 lung segments involved in their study. 4 As mentioned above, most studies found bilateral lung disease involvement.
Although, these studies attract significant interest and are very appropriate for the current outbreak, it would certainly benefit from further discussion and refinement. Most of the radiological findings presented in these patients are generic and can be seen in many systemic infectious processes such as pneumonia (viral or bacterial), inflammatory conditions (inflammatory lung diseases, vasculitis) and other cardiac etiologies affecting lung parenchyma such as decompensated congestive heart failure. Even though the authors described cases with confirmed COVID-19, the CT imaging findings could also be due to multiple underlying medical comorbidities, fluid status (volume overload) and other concomitant infections (superadded pneumonia with coronavirus infection).
It would also be interesting to know the difference in the radiological features of patients that required mechanical ventilation (MV) versus patients who did not, since positive pressure ventilation can affect the radiological findings in these patients which none of the studies have reported so far. Knowing the radiological differences in patients that require MV versus in patients that had a more favorable course may have prognostic importance. 
ARTICLE IN PRESS
Heart & Lung 000 (2020) 1À2
Contents lists available at ScienceDirect
Heart & Lung journal homepage: www.heartandlung.com Wu et al. also found a significant correlation between the pulmonary inflammation index (PII) and lab results-lymphocyte and monocyte count, serum CRP levels, serum procalcitonin levels, days from illness onset and temperature (P < 0.05). Based on these results, it can be suggested that the patients with the worst blood/ laboratory findings are also expected to have worse PII index values. 4, 5 Finally, it is not surprising to find basal lung involvements (right or left), since ill patients would be less ambulatory and hence, likely to develop radiological changes in the dependent areas of the lungs. There are no studies focusing especially on immunocompromised patients, but it is expected that such patients are expected to develop more complications based on the previously established literature. 6À8 Despite the limitations as discussed above, we believe that similar studies analyzing the COVID-19 CT imaging findings can provide valuable information to the treating physicians and radiologists. However, as of now, it seems that COVID-19 lacks any specific or pathognomonic CT findings limiting its utility for complete reliability and bedside application. Further characterization of radiological features in the right context of patient-specific comorbidities and relation with other medical conditions (superadded pneumonia, underlying heart failure or fluid overload and rheumatological diseases) would definitely add value to the knowledge in this field and educate the treating clinicians, pool of internists, pulmonologists, intensivists and radiologists alike.
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